Anti-Asthmatic Agents Concept

subject area of

• OX 40L blockade and allergen‐induced airway responses in subjects with mild asthma  Academic Article
• A Nonsteroidal Glucocorticoid Receptor Agonist Inhibits Allergen-induced Late Asthmatic Responses  Academic Article
• A halotyrosine antibody that detects increased protein modifications in asthma patients  Academic Article
• A new perspective on concepts of asthma severity and control  Academic Article
• A patient decision aid for mild asthma: Navigating a new asthma treatment paradigm  Academic Article
• A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study).  Academic Article
• A randomized, placebo‐controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)  Academic Article
• A summary of the new GINA strategy: a roadmap to asthma control  Academic Article
• A systematic review of adverse drug events associated with administration of common asthma medications in children  Academic Article
• Adding formoterol to budesonide in moderate asthma—health economic results from the FACET study  Academic Article
• Aerosols and devices  Academic Article
• Age trends in direct medical costs of pediatric asthma: A population study  Academic Article
• Airway smooth muscle as a target of asthma therapy: history and new directions  Academic Article
• Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for people with asthma  Academic Article
• Antileukotrienes, asthma pathogenesis and the pharmaceutical industry.  Academic Article
• Anti–Interleukin-5 Monoclonal Antibody to Treat Severe Eosinophilic Asthma  Academic Article
• Are New Asthma Therapies Needed?  Academic Article
• Association between parental perception of children's vulnerability to illness and management of children's asthma  Academic Article
• Asthma Control, Airway Mucus, and 129Xe MRI Ventilation After a Single Benralizumab Dose  Academic Article
• Asthma and Exercise-Induced Bronchoconstriction in Athletes  Academic Article
• Asthma exacerbations on benralizumab are largely non‐eosinophilic  Academic Article
• Asthma exacerbations {middle dot} 1: Epidemiology  Academic Article
• Asthma maintenance and reliever therapy  Academic Article
• Asthma maintenance and reliever therapy  Academic Article
• Asthma progression and mortality: the role of inhaled corticosteroids  Academic Article
• Asthma therapy: how far have we come, why did we fail and where should we go next?  Academic Article
• Asthma treatment: antileukotriene drugs.  Academic Article
• Asthma: management of severe disease  Academic Article
• At-risk registers integrated into primary care to stop asthma crises in the UK (ARRISA-UK): study protocol for a pragmatic, cluster randomised trial with nested health economic and process evaluations  Academic Article
• Attenuation of the September Epidemic of Asthma Exacerbations in Children: A Randomized, Controlled Trial of Montelukast Added to Usual Therapy  Academic Article
• Benralizumab for Prednisone-Dependent Eosinophilic Asthma Associated With Novel STAT3 Loss of Function Mutation  Academic Article
• Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial  Academic Article
• Blood or sputum eosinophils to guide asthma therapy?  Academic Article
• Bronchial Thermoplasty for Asthma  Academic Article
• COST-effectiveness of salmeterol/fluticasone propionate combination (Advair®) in uncontrolled asthma in Canada  Academic Article
• Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies  Academic Article
• Choose better device to treat asthma and put on a happy face.  Academic Article
• Clinical Comparisons of Inhaler Systems: What are the Important Aspects?  Academic Article
• Clinical Models to Compare the Safety and Efficacy of Inhaled Corticosteroids in Patients with Asthma  Academic Article
• Clinical applications of assessment of airway inflammation using induced sputum  Academic Article
• Clinically Important Improvements in Asthma-Specific Quality of Life, But No Difference in Conventional Clinical Indexes in Patients Changed From Conventional Beclomethasone Dipropionate to Approximately Half the Dose of Extrafine Beclomethasone Dipropionate  Academic Article
• Combined Analysis of Asthma Safety Trials of Long-Acting β₂-Agonists  Academic Article
• Combining LABA and ICS in patients with severe COPD  Academic Article
• Comparison of efficiency and preference of metal and plastic spacers in preschool children  Academic Article
• Comparison of reported prevalences of recent asthma in longitudinal and cross-sectional studies  Academic Article
• Comparison of the Effect of Low-Dose Ciclesonide and Fixed-Dose Fluticasone Propionate and Salmeterol Combination on Long-term Asthma Control  Academic Article
• Cytokines or Their Antagonists for the Treatment of Asthma  Academic Article
• Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations  Academic Article
• Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines  Academic Article
• Direct and indirect bronchoprovocation tests in dose‐response studies of inhaled corticosteroids: Past, present, and future directions  Academic Article
• Disease-modifying anti-asthmatic drugs  Academic Article
• Does early intervention with inhaled corticosteroids alter the natural history of mild persistent asthma?  Academic Article
• Does the current stepwise approach to asthma pharmacotherapy encourage over-treatment?  Academic Article
• Dose-response effects of TPI ASM8 in asthmatics after allergen  Academic Article
• Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: the Steroid Treatment As Regular Therapy in early asthma (START) trial  Academic Article
• Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial  Academic Article
• Effect of Add-on Devices for Aerosol Drug Delivery: Deposition Studies and Clinical Aspects  Academic Article
• Effect of anti‐IL‐5 biologics on weight and body mass index  Academic Article
• Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia  Academic Article
• Effects of furosemide on allergic asthmatic responses in mice  Academic Article
• Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma  Academic Article
• Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial  Academic Article
• Efficacy and safety of reslizumab in patients with moderate to severe eosinophilic asthma  Academic Article
• Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial  Academic Article
• Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma  Academic Article
• Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma  Academic Article
• Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma  Academic Article
• Efficacy of Intravenous Reslizumab in Oral Corticosteroid–Dependent Asthma  Academic Article
• Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment  Academic Article
• Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma  Academic Article
• Emerging airway smooth muscle targets to treat asthma  Academic Article
• Endotypes of difficult-to-control asthma in inner-city African American children  Academic Article
• Eosinophilic Endotype of Asthma  Academic Article
• Evaluation of Asthma Control by Physicians and Patients: Comparison with Current Guidelines  Academic Article
• Exacerbations of Severe Asthma While on Anti–IL-5 Biologics  Academic Article
• From Bench to Bedside  Academic Article
• GM-CSF and Dendritic Cells in Allergic Airway Inflammation: Basic Mechanisms and Prospects for Therapeutic Intervention  Academic Article
• Global guidelines for asthma management. Summary of the current status and future challenges  Academic Article
• Global strategy for asthma management and prevention: GINA executive summary  Academic Article
• Glucocorticoid Sparing of Benralizumab in Asthma  Academic Article
• Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society.  Academic Article
• How much is too much? The treatment of mild asthma  Academic Article
• Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire  Academic Article
• Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients  Academic Article
• Inhaled Corticosteroid Therapy in Newly Detected Mild Asthma  Academic Article
• Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma  Academic Article
• Is Asthma a Risk Factor for Dental Caries? Findings from a Cohort Study  Academic Article
• Is it safe to use long‑acting β‑agonists in asthma and chronic obstructive pulmonary disease? Implications of recent trials and meta‑analyses  Academic Article
• Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy?  Academic Article
• Leukotriene Antagonists as First-Line or Add-on Asthma-Controller Therapy  Academic Article
• Levalbuterol has not been established to have therapeutic advantage over racemic albuterol  Academic Article
• Long-Acting β₂-Agonist Step-off in Patients With Controlled Asthma  Academic Article
• Long-acting β-Agonists, Tachyphylaxis, and Corticosteroids  Academic Article
• Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial  Academic Article
• Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma  Academic Article
• Management of asthma exacerbation in adults – guidelines for primary care doctors  Academic Article
• Management of asthma in adults  Academic Article
• Management of suspected acute viral upper respiratory tract infection in children with intranasal sodium cromoglicate: a randomised controlled trial  Academic Article
• Measurement characteristics of two asthma symptom diary scales for use in clinical trials  Academic Article
• Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma  Academic Article
• Measurement properties and interpretation of three shortened versions of the asthma control questionnaire  Academic Article
• Measuring Asthma Control  Academic Article
• Measuring Total and Regional Lung Deposition Using Inhaled Radiotracers  Academic Article
• Mechanisms and treatments for severe, steroid‐resistant allergic airway disease and asthma  Academic Article
• Medical algorithms: Approach to adult asthma exacerbations  Academic Article
• Metered-dose inhaler ipratropium bromide in moderate acute asthma in children: A single-blinded randomised controlled trial  Academic Article
• Methacholine test and the diagnosis of asthma  Academic Article
• Monitoring eosinophils to guide therapy with biologics in asthma: does the compartment matter?  Academic Article
• Monoclonal antibodies for the treatment of refractory asthma  Academic Article
• Montelukast Treatment Attenuates the Increase in Myofibroblasts Following Low-Dose Allergen Challenge  Academic Article
• Montelukast as Add-On Therapy with Inhaled Corticosteroids Alone or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (the RADAR Trial)  Academic Article
• New Delivery Systems and Propellants  Academic Article
• New paradigm in asthma management: Switching between biologics!  Academic Article
• New treatment approaches for asthma  Academic Article
• Normalisation of MRI ventilation heterogeneity in severe asthma by dupilumab  Academic Article
• Novel therapy for asthma  Academic Article
• Omalizumab for asthma in adults and children  Academic Article
• Once-daily ciclesonide 80 or 320μg for 12 weeks is safe and effective in patients with persistent asthma  Academic Article
• Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone  Academic Article
• Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma  Academic Article
• Once‐daily fluticasone furoate 50 mcg in mild‐to‐moderate asthma: a 24‐week placebo‐controlled randomized trial  Academic Article
• Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma  Academic Article
• Overall asthma control: The relationship between current control and future risk  Academic Article
• Pharmacologic Interventions to Reduce the Risk of Asthma Exacerbations  Academic Article
• Pharmacologic modulation of airway inflammation  Conference Paper
• Pharmacotherapeutic management of asthma in pregnancy and the effect of sex hormones  Academic Article
• Positioning As-needed Budesonide–Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2  Academic Article
• Potential Masking Effects of Salmeterol on Airway Inflammation in Asthma  Academic Article
• Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects  Academic Article
• Predicting the clinical course of suspected acute viral upper respiratory tract infection in children  Academic Article
• Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting β2-agonist, in patients with mild asthma  Academic Article
• Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D4–receptor antagonist cinalukast☆☆☆★  Academic Article
• Pulmonary function testing in the Emergency Department and medications prescribed at discharge: results of the Multinational Acute asthma Management, Burden, and Outcomes (MAMBO) study  Academic Article
• Quality of life questionnaires: Does statistically significant = clinically important?  Academic Article
• Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids  Academic Article
• Real-world health care utilization and effectiveness of omalizumab for the treatment of severe asthma  Academic Article
• Recent Advances in the Pathophysiology of Asthma  Academic Article
• Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events  Academic Article
• Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events  Academic Article
• Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events  Academic Article
• Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events  Academic Article
• Relationship between quality of life and clinical status in asthma: a factor analysis  Academic Article
• Reply to Yilmaz: Selection of Biologics for Type 2–High Asthma  Academic Article
• Risankizumab in Severe Asthma — A Phase 2a, Placebo-Controlled Trial  Academic Article
• Risk of congenital malformations associated with treatment of asthma during early pregnancy  Academic Article
• Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids  Academic Article
• Role of Biologics in Asthma  Academic Article
• Role of Leukotrienes and Leukotriene Receptor Antagonists in Asthma  Academic Article
• Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma  Academic Article
• Sample sizes for clinical trials using sputum eosinophils as a primary outcome  Academic Article
• Severe asthma: future treatments  Academic Article
• Significant variability in response to inhaled corticosteroids for persistent asthma  Academic Article
• Single-dose desloratadine and montelukast and allergen-induced late airway responses  Academic Article
• Sputum Hyaluronan and Versican in Severe Eosinophilic Asthma  Academic Article
• Sputum autoantibodies in patients with severe eosinophilic asthma  Academic Article
• Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena  Academic Article
• TNF-αDysregulation in Asthma: Relationship to Ongoing Corticosteroid Therapy  Academic Article
• The GINA asthma strategy report: what’s new for primary care?  Academic Article
• The Global Initiative for Asthma (GINA): 25 years later  Academic Article
• The September epidemic of asthma exacerbations in children: A search for etiology  Academic Article
• The effect of montelukast, budesonide alone, and in combination on exercise-induced bronchoconstriction  Academic Article
• The effects of a CCR3 inhibitor, AXP1275, on allergen-induced airway responses in adults with mild-to-moderate atopic asthma  Conference Paper
• The management of mild asthma  Academic Article
• The safety of long-acting beta-agonists: More evidence is needed  Academic Article
• The use of sputum cell counts to evaluate asthma medications  Academic Article
• The utility of methacholine airway responsiveness measurements in evaluating anti-asthma drugs☆☆☆★★★  Academic Article
• Therapeutic implications of ‘neutrophilic asthma’  Academic Article
• Therapeutic strategies to reduce asthma exacerbations  Academic Article
• Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma  Academic Article
• Timing is everything: Targeting IgE to reduce asthma exacerbation risk  Academic Article
• Tiotropium for the treatment of asthma: a drug safety evaluation  Academic Article
• To Inhale or Not to Inhale: Is That the Question? A Simple Method of DPI Instruction  Academic Article
• Treatment of Asthma with Drugs Modifying the Leukotriene Pathway  Academic Article
• Treatment of mild asthma  Academic Article
• Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma  Academic Article
• Understanding the September asthma epidemic  Academic Article
• Use of Asthma Medication During Gestation and Risk of Specific Congenital Anomalies  Academic Article
• Use of peak expiratory flow meters in adults: practical aspects.  Academic Article
• Variations and Gaps in Management of Acute Asthma in Ontario Emergency Departments  Academic Article
• What Is New Since the Last (1999) Canadian Asthma Consensus Guidelines?  Academic Article
• What have we learnt about asthma control from trials of budesonide/formoterol as maintenance and reliever?  Academic Article
• [Drug prescription to 4-year-old children in the county of Vestfold].  Academic Article
• [Treatment of asthma--an analysis of clinical judgment among general practitioners].  Academic Article